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ABSTRACT
Objectives: Ghrelin levels can play an important role in maintaining the energy balance of pregnant women. Therefore, 
we investigated the relationship between HG and Ghrelin.
Material and methods: 50 female patients admitted to the VAN Yüzüncü Yıl University, Gynecology and Obstetrics Depart-
ment were evaluated. The patients were divided into two groups: Group 1 included 25 pregnant women with HG, Group 2  
included 25 healthy pregnant women.
Results: The two groups showed similarities in terms of age, gravidity, B-HCG and gestational age. There was no statistically 
significant difference between the two groups in terms of the Ghrelin levels (p = 0.867).
Conclusions: This study shows that there is no difference between Ghrelin levels and HG during pregnancy. Increased 
Ghrelin in previous studies was attributed to low oral intake. Another study reported lower Ghrelin levels are not the result 
of, but are rather the cause of, reduced oral intake during. The balancing of these two conditions does not lead to a change 
in the level of Ghrelin.
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INTRODUCTION
Nausea and vomiting can be seen in 80% of pregnant 
women in the first months of pregnancy. Hyperemesis 
gravidarum (HG), a severe form of nausea and vomiting, 
occurs in about 0.3–3% of all pregnancies. Severe nausea 
and vomiting occurring more than three times a day in 
patients with ketonuria and more than 5% weight loss 
are diagnosed with HG. Its aetiology has yet to be fully 
elucidated [1–3]. 
Ghrelin, which is a gastric hormone that regulates food 
intake, energy metabolism and growth hormone secretion, 
attracts attention as an appetizing hormone. Ghrelin levels 
increases before a meal and decreases after a meal [4, 5].
There have been many studies in the literature between 
HG and Ghrelin. Ghrelin levels can play an essential role 
in maintaining the energy balance of pregnant women. 
Therefore, we investigated the relationship between HG 
and Ghrelin.
MATERIAL AND METHODS
In this study, 50 female patients admitted to the VAN 
Yüzüncü Yıl University, Gynecology and Obstetrics Depart-
ment were evaluated. The patients were divided into two 
groups: Group 1 included 25 pregnant women with HG, 
Group 2 included 25 healthy pregnant women. 
Patients with comorbid diseases, such as trophoblas-
tic diseases, gestational diabetes, preeclampsia, thyroid 
diseases, infectious diseases, inflammatory diseases, renal 
diseases, hepatic diseases and psychiatric disorders, as well 
as patients with smoking and alcohol habits, those with 
chronic medication use and those with pregnancies over 
10 weeks were excluded from the study. The gestational 
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weeks were determined according to the patient’s last men-
strual period and by ultrasonography. 
Blood is taken from the antecubital vein and centrifuged 
at 1500 rpm for 15 minutes (core and NF 800, Turkey,) is 
obtained after Sera removed to Eppendorf tubes and stored 
at -80°C. Serum samples prepared in this way were sent to 
Bolu Abant Izzet Baysal University Faculty of Medicine in 
order to study. Samples were measured using the Bioven-
dor Human Acylated Ghrelin ELISA kit (No: RD194062400R, 
Biovendor GMBH, Heidelberg ). Results are given in pg/mL.
Written and verbal informed consent was obtained 
from all of the volunteers. The ethical principles for medi-
cal research involving humanitarian issues envisaged in the 
Declaration of Helsinki were applied.
Statistical analysis
Numerical variables were figured as mean plus/minus 
standard deviation. For the comparative analysis between 
the groups (case vs control), a χ2 test was used for the 
categorical variables and either a Student’s t-test or the 
Mann–Whitney U test was used for the continuous vari-
ables. Differences were considered significant at p < 0.05. 
RESULTS
Group 1 consisted of 25 patients with ketone positive 
(HG), Group 2 consisted of 25 healthy pregnant women who 
were admitted to the hospital for routine controls. Clinical 
and laboratory results are shown in Table 1. No significant 
differences were found between the groups in terms of the 
maternal age, gestational age, gravidity and B-HCG. There 
was no statistically significant difference between the two 
groups in terms of the Ghrelin (p = 0.867).
DISCUSSION
In this study, we investigated Ghrelin changes between 
pregnant women with HG and healthy pregnant control 
group. Ghrelin levels were similar in both groups. 
Although many studies have been conducted on HG, 
a clear decision on its etiology has not been disclosed. Some 
studies have investigated other peptides, such as leptin, 
that affect food intake and appetite. Nausea and vomiting 
and changes in leptin levels have been studied [6, 7], but 
these studies have failed to explain the aetiology. For this 
reason, the hormone Ghrelin has gained importance with 
the thought that it may be involved in the aetiology of HG, 
and many studies have been done on this subject. 
Oruç et al. [8] found that Ghrelin levels were significantly 
increased in patients with HG compared to normal pregnant 
women, which may be due to the need for the maternal 
organs to react with a compensatory mechanism to recover 
energy. The level of Ghrelin increases before eating and de-
creases after a meal [9], which means plasma Ghrelin and oral 
intake correlate negatively. In contrast, Kaygusuz et al. [10] 
found higher Ghrelin levels in the control group than in the 
HG group. This suggests that the lower Ghrelin levels are not 
the result of, but are instead the cause of, reduced oral intake 
during HG. Wibowo et al. [11] compared Ghrelin levels in 
patients with HG treated with vitamin B6 supplementation 
divided into two groups. However, it found no difference 
between two groups. In a study by Chittumma et al. [12], 
vitamin B6 was given to women with hyperemesis, B 6 was 
useful for the treatment of HG. Since nausea and vomiting 
were reduced in patients receiving vitamin supplements, their 
energy requirement would be reduced, and Ghrelin levels 
would be expected to decrease, but the Wibowo study, found 
no difference in Ghrelin levels between HG patients given 
B6. We think this is a situation that supports our study. In-
creased Ghrelin in previous studies was attributed to low oral 
intake. Another study reported lower Ghrelin levels are not 
the result of but are instead the cause of, reduced oral intake 
during [8, 10]. The balancing of these two conditions does 
not lead to a change in the level of Ghrelin. This suggests that 
the aetiology of HG requires more comprehensive studies.
CONCLUSIONS
The limitation of this study was that we had a small 
number of patients. Secondly, we could not measure the 
pre-pregnancy Ghrelin of these pregnant women. Thirdly, 
we did not investigate other factors that affect Ghrelin levels 
in maternal serum.
This study shows that there is no difference between 
Ghrelin levels and HG during pregnancy. We do not know 
the exact cause of this mechanism. However, we think that 
many mechanisms balance this situation.  We believe that 
more extensive studies are needed to investigate the role 
of Ghrelin in HG pathology.
REFERENCES
1. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl 
J Med. 2010; 363(16): 1544–1550, doi: 10.1056/NEJMcp1003896, indexed 
in Pubmed: 20942670.
Table 1. Baseline criteria and treatment outcome of the groups
Group 1
HG (n = 25)
Group 2
Control group 
(n = 25)
P 
value
Age (years) (mean ± SD) 27.60 ± 4.8 28.92 ± 5.3 0.4
Gestational age (weeks) 7.96 ± 1,3 7.2 ± 1.4 0.2
Gravidity 4,04 ± 1.45 4.22 ± 1.34 0.8
Ghrelin (pg/mL) 55.2 ± 14.7 54.52 ± 13.7 0.86
B-HCG 94662 ± 72040 71099 ± 65061 0.23
Data are mean ± standard deviation
701
Serhat Ege et al., Ghrelin in hyperemesis gravidarum
www. journals.viamedica.pl/ginekologia_polska
2. Goodwin TM. Hyperemesis gravidarum. Clin Obstet Gynecol. 1998; 
41(3): 597–605, doi: 10.1097/00003081-199809000-00014, indexed in 
Pubmed: 9742356.
3. Rashid M, Rashid MH, Malik F, et al. Hyperemesis gravidarum and fetal 
gender: a retrospective study. J Obstet Gynaecol. 2012; 32(5): 475–478, 
doi: 10.3109/01443615.2012.666580, indexed in Pubmed: 22663323.
4. Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an endogenous growth 
hormone secretagogue, is a novel orexigenic peptide that antagonizes 
leptin action through the activation of hypothalamic neuropeptide Y/Y1 
receptor pathway. Diabetes. 2001; 50(2): 227–232, doi: 10.2337/diabe-
tes.50.2.227, indexed in Pubmed: 11272130.
5. De Vriese C, Delporte C. Ghrelin: a new peptide regulating growth 
hormone release and food intake. Int J Biochem Cell Biol. 2008; 40(8): 
1420–1424, doi: 10.1016/j.biocel.2007.04.020, indexed in Pubmed: 
17544318.
6. Aka N, Atalay S, Sayharman S, et al. Leptin and leptin receptor levels 
in pregnant women with hyperemesis gravidarum. Aust N Z J Obstet 
Gynaecol. 2006; 46(4): 274–277, doi: 10.1111/j.1479-828X.2006.00590.x, 
indexed in Pubmed: 16866785.
7. Arslan EO, Cengiz L, Arslan M. Thyroid function in hyperemesis gravidar-
um and correlation with serum leptin levels. Int J Gynaecol Obstet. 
2003; 83(2): 187–188, doi: 10.1016/s0020-7292(03)00130-9, indexed in 
Pubmed: 14550594.
8. Oruç AS, Mert I, Akturk M, et al. Ghrelin and motilin levels in hyperem-
esis gravidarum. Arch Gynecol Obstet. 2013; 287(6): 1087–1092, doi: 
10.1007/s00404-012-2705-8, indexed in Pubmed: 23296465.
9. Tschöp M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating 
human ghrelin levels. J Endocrinol Invest. 2001; 24(6): RC19–RC21, doi: 
10.1007/BF03351037, indexed in Pubmed: 11434675.
10. Kaygusuz İ, Gümüş İİ, Yildirim M, et al. Association between 
maternal ghrelin levels and hyperemesis gravidarum. TURK-
ISH JOURNAL OF MEDICAL SCIENCES. 2013; 43: 790–794, doi: 
10.3906/sag-1209-9.
11. Wibowo N, Purwosunu Y, Sekizawa A, et al. Vitamin B₆ supplementation 
in pregnant women with nausea and vomiting. Int J Gynaecol Obstet. 
2012; 116(3): 206–210, doi: 10.1016/j.ijgo.2011.09.030, indexed in 
Pubmed: 22189065.
12. Chittumma P, Kaewkiattikun K, Wiriyasiriwach B. Comparison of the 
effectiveness of ginger and vitamin B6 for treatment of nausea and 
vomiting in early pregnancy: a randomized double-blind controlled 
trial. J Med Assoc Thai. 2007; 90(1): 15–20, indexed in Pubmed: 
17621727.
